Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Anteris Technologies Global Corp.
13G/A
Amendment 1
AVR · 03675P102
|
4.7% |
8/14/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 4.7% | ||||
| Joseph Edelman | 4.7% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.7% | ||||
|
Evolus, Inc.
13G/A
Amendment 4
EOLS · 30052C107
|
3.8% |
8/14/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 3.8% | ||||
| Joseph Edelman | 3.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 3.8% | ||||
|
Aldeyra Therapeutics, Inc.
13G/A
Amendment 13
ALDX · 01438T106
|
6.8% |
8/14/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 6.8% | ||||
| Joseph Edelman | 6.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.8% | ||||
|
Arcellx, Inc.
13G/A
Amendment 4
ACLX · 03940C100
|
4.5% |
8/14/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 4.5% | ||||
| Joseph Edelman | 4.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.5% | ||||
|
Verona Pharma plc
13G/A
Amendment 2
VRNA · 925050106
|
6.4% |
8/14/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 6.4% | ||||
| Joseph Edelman | 6.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.4% | ||||
|
Beta Bionics, Inc.
13G/A
Amendment 1
BBNX · 08659B102
|
3.7% |
8/7/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 3.7% | ||||
| Joseph Edelman | 3.7% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 3.7% | ||||
|
Celcuity Inc.
13G
CELC · 15102K100
|
6.6% |
8/4/2025
Event 7/30/2025
|
|||
| Perceptive Advisors LLC | 6.6% | ||||
| Joseph Edelman | 6.6% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.6% | ||||
|
Celcuity Inc.
13G/A
Amendment 3
CELC · 15102K100
|
4.3% |
8/4/2025
Event 6/30/2025
|
|||
| Perceptive Advisors LLC | 4.3% | ||||
| Joseph Edelman | 4.3% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.3% | ||||
|
Praxis Precision Medicines, Inc.
13G
PRAX · 74006W207
|
6.7% |
7/22/2025
Event 7/15/2025
|
|||
| Perceptive Advisors LLC | 6.7% | ||||
| Joseph Edelman | 6.7% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.7% | ||||
|
Nautilus Biotechnology, Inc.
13D/A
Amendment 4
NAUT · 63909J108
|
10.1% |
6/24/2025
Event 6/20/2025
|
|||
| Perceptive Advisors LLC | 10.1% | ||||
| Joseph Edelman | 10.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||||
|
Acrivon Therapeutics, Inc.
13G/A
Amendment 5
ACRV · 004890109
|
0% |
6/4/2025
Event 6/2/2025
|
|||
| Perceptive Advisors LLC | 0% | ||||
| Joseph Edelman | 0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | ||||
|
Rhythm Pharmaceuticals, Inc.
13G/A
Amendment 1
RYTM · 76243J105
|
6.8% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 6.8% | ||||
| Joseph Edelman | 6.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.5% | ||||
| Perceptive Discovery ID LP | 2.2% | ||||
|
Amylyx Pharmaceuticals, Inc.
13G/A
Amendment 2
AMLX · 03237H101
|
8.8% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 8.8% | ||||
| Joseph Edelman | 8.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 8.8% | ||||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 1
DRUG · 10919W405
|
6.3% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 6.3% | ||||
| Joseph Edelman | 6.3% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.3% | ||||
|
Beta Bionics, Inc.
13G
BBNX · 08659B102
|
5.1% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 5.1% | ||||
| Joseph Edelman | 5.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.1% | ||||
|
Verrica Pharmaceuticals, Inc.
13G/A
Amendment 10
VRCA · 92511W108
|
1.6% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 1.6% | ||||
| Joseph Edelman | 1.6% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 1.6% | ||||
|
Contineum Therapeutics, Inc.
13G/A
Amendment 2
CTNM · 21217B100
|
7.5% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 7.5% | ||||
| Joseph Edelman | 7.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 7.5% | ||||
|
Amicus Therapeutics, Inc.
13G/A
Amendment 4
FOLD · 03152W109
|
7.0% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 7.0% | ||||
| Joseph Edelman | 7.0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 7.0% | ||||
|
Arcellx, Inc.
13G/A
Amendment 3
ACLX · 03940C100
|
5.3% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 5.3% | ||||
| Joseph Edelman | 5.3% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.3% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 2
PRAX · 74006W207
|
4.8% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 4.8% | ||||
| Joseph Edelman | 4.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.8% | ||||
|
Evolus, Inc.
13G/A
Amendment 3
EOLS · 30052C107
|
6.4% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 6.4% | ||||
| Joseph Edelman | 6.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.4% | ||||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 1
EWTX · 28036F105
|
6.1% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 6.1% | ||||
| Joseph Edelman | 6.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.1% | ||||
|
Outset Medical, Inc.
13G/A
Amendment 1
OM · 690145206
|
6.7% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 6.7% | ||||
| Joseph Edelman | 6.7% | ||||
| Perceptive Credit Advisors, LLC | 6.7% | ||||
| Perceptive Credit Holdings IV, LP | 6.7% | ||||
|
Surrozen, Inc.
13G/A
Amendment 1
SRZN · 86889P208
|
1.9% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 1.9% | ||||
| Joseph Edelman | 1.9% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 1.9% | ||||
|
Ensysce Biosciences, Inc.
13G/A
Amendment 3
ENSC · 293602504
|
3.7% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 3.7% | ||||
| Joseph Edelman | 3.7% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 3.7% | ||||
|
Biodesix, Inc.
13G
BDSX · 09075X108
|
5.1% |
5/15/2025
Event 5/12/2025
|
|||
| Perceptive Advisors LLC | 5.1% | ||||
| Joseph Edelman | 5.1% | ||||
| Perceptive Credit Advisors LLC | 5.1% | ||||
| Pcof Eq Aiv IV, LP | 0.8% | ||||
| Perceptive Credit Holdings IV, LP | 4.3% | ||||
|
Instil Bio, Inc.
13G/A
Amendment 1
TIL · 45783C200
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 0% | ||||
| Joseph Edelman | 0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | ||||
|
Traws Pharma, Inc.
13G/A
Amendment 1
TRAW · 68232V884
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 10.0% | ||||
| Joseph Edelman | 10.0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||||
|
Iovance Biotherapeutics, Inc.
13G/A
Amendment 3
IOVA · 462260100
|
3.8% |
5/15/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 3.8% | ||||
| Joseph Edelman | 3.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 3.8% | ||||
|
Acrivon Therapeutics, Inc.
13G/A
Amendment 4
ACRV · 004890109
|
9.9% |
5/1/2025
Event 4/29/2025
|
|||
| Perceptive Advisors LLC | 9.9% | ||||
| Joseph Edelman | 9.9% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 9.9% | ||||
|
CARGO Therapeutics, Inc.
13G/A
Amendment 2
CRGX · 14179K101
|
2.5% |
4/23/2025
Event 4/23/2025
|
|||
| Perceptive Advisors LLC | 2.5% | ||||
| Joseph Edelman | 2.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | ||||
| Perceptive Xontogeny Venture Fund II, L.P. | 2.5% | ||||
|
Aldeyra Therapeutics, Inc.
13G/A
Amendment 12
ALDX · 01438T106
|
8.2% |
4/7/2025
Event 4/3/2025
|
|||
| Perceptive Advisors LLC | 8.2% | ||||
| Joseph Edelman | 8.2% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 8.2% | ||||
|
Ensysce Biosciences, Inc.
13G/A
Amendment 2
ENSC · 293602504
|
5.3% |
4/3/2025
Event 3/31/2025
|
|||
| Perceptive Advisors LLC | 5.3% | ||||
| Joseph Edelman | 5.3% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.3% | ||||
|
Opus Genetics, Inc.
13G
IRD · 67577R102
|
10.0% |
3/31/2025
Event 3/24/2025
|
|||
| Perceptive Advisors LLC | 10.0% | ||||
| Joseph Edelman | 10.0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||||
|
Inventiva S.A.
13G
IVA · 46124U107
|
5.8% |
3/26/2025
Event 12/13/2024
|
|||
| Perceptive Advisors LLC | 5.8% | ||||
| Joseph Edelman | 5.8% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.8% | ||||
|
Trinity Biotech plc
13D/A
Amendment 4
TRIB · 896438504
|
19.8% |
3/25/2025
Event 3/21/2025
|
|||
| Perceptive Advisors LLC | 19.8% | ||||
| Perceptive Credit Advisors LLC | 19.8% | ||||
| Joseph Edelman | 19.8% | ||||
| Perceptive Credit Holdings II, L.P. | 10.6% | ||||
| Perceptive Credit Holdings III, L.P. | 9.2% | ||||
|
Outset Medical, Inc.
13G
OM · 690145107
|
9.5% |
2/28/2025
Event 1/8/2025
|
|||
| Perceptive Advisors LLC | 9.5% | ||||
| Joseph Edelman | 9.5% | ||||
| Perceptive Credit Advisors LLC | 9.5% | ||||
| Perceptive Credit Holdings IV, LP | 9.5% | ||||
|
Edgewise Therapeutics, Inc.
13G
EWTX · 28036F105
|
5.5% |
2/21/2025
Event 2/13/2025
|
|||
| Perceptive Advisors LLC | 5.5% | ||||
| Joseph Edelman | 5.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.5% | ||||
|
Solid Biosciences Inc.
13D/A
Amendment 8
SLDB · 83422E204
|
15.6% |
2/21/2025
Event 2/19/2025
|
|||
| Perceptive Advisors LLC | 15.6% | ||||
| Joseph Edelman | 15.6% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 15.5% | ||||
| Perceptive Xontogeny Venture Fund, LP | 0.1% | ||||
|
Trinity Biotech plc
13D/A
Amendment 3
TRIB · 896438504
|
20.9% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 20.9% | ||||
| Perceptive Credit Advisors LLC | 20.9% | ||||
| Joseph Edelman | 20.9% | ||||
| Perceptive Credit Holdings II, L.P. | 11.4% | ||||
| Perceptive Credit Holdings III, L.P. | 9.7% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 3
FBRX · 34962G208
|
2.5% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 2.5% | ||||
| Joseph Edelman | 2.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 2.5% | ||||
|
Applied Therapeutics, Inc.
13G/A
Amendment 3
APLT · 03828A101
|
2.4% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 2.4% | ||||
| Joseph Edelman | 2.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 2.4% | ||||
|
Biodesix, Inc.
13G/A
Amendment 1
BDSX · 09075X108
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 4.5% | ||||
| Joseph Edelman | 4.5% | ||||
| Perceptive Credit Advisors LLC | 4.5% | ||||
| Pcof Eq Aiv IV, LP | 0.8% | ||||
| Perceptive Credit Holdings IV, LP | 3.7% | ||||
|
Contineum Therapeutics, Inc.
13G/A
Amendment 1
CTNM · 21217B100
|
5.6% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 5.6% | ||||
| Joseph Edelman | 5.6% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.6% | ||||
|
RAPT Therapeutics, Inc.
13G/A
Amendment 5
RAPT · 75382E109
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 4.5% | ||||
| Joseph Edelman | 4.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.5% | ||||
|
Ensysce Biosciences, Inc.
13G/A
Amendment 1
ENSC · 293602504
|
0.4% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 0.4% | ||||
| Joseph Edelman | 0.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 0.4% | ||||
|
Surrozen, Inc.
13G
SRZN · 86889P208
|
5.1% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 5.1% | ||||
| Joseph Edelman | 5.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.1% | ||||
|
Amylyx Pharmaceuticals, Inc.
13G/A
Amendment 1
AMLX · 03237H101
|
7.9% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 7.9% | ||||
| Joseph Edelman | 7.9% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 7.9% | ||||
|
Amicus Therapeutics, Inc.
13G/A
Amendment 3
FOLD · 03152W109
|
8.1% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 8.1% | ||||
| Joseph Edelman | 8.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 8.1% | ||||
|
Celcuity Inc.
13G/A
Amendment 2
CELC · 15102K100
|
6.4% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 6.4% | ||||
| Joseph Edelman | 6.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.4% | ||||
|
Spyre Therapeutics, Inc.
13G/A
Amendment 3
SYRE · 00773J202
|
4.4% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 4.4% | ||||
| Joseph Edelman | 4.4% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 4.4% | ||||
|
Iovance Biotherapeutics, Inc.
13G/A
Amendment 2
IOVA · 462260100
|
7.3% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 7.3% | ||||
| Joseph Edelman | 7.3% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 7.3% | ||||
|
Adagio Medical Holdings, Inc.
13G/A
Amendment 1
ADGM · 00534B100
|
73.6% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 73.6% | ||||
| Joseph Edelman | 73.6% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 72.6% | ||||
| C2 Life Sciences LLC | 1.0% | ||||
|
Anteris Technologies Global Corp.
13G
AVR · 03675P102
|
6.7% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 6.7% | ||||
| Joseph Edelman | 6.7% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 6.7% | ||||
|
Verrica Pharmaceuticals Inc.
13G/A
Amendment 9
VRCA · 92511W108
|
5.1% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 5.1% | ||||
| Joseph Edelman | 5.1% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 5.1% | ||||
|
Praxis Precision Medicines, Inc
13G/A
Amendment 1
PRAX · 74006W207
|
9.5% |
2/14/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 9.5% | ||||
| Joseph Edelman | 9.5% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 9.5% | ||||
|
Nautilus Biotechnology, Inc.
13D/A
Amendment 3
NAUT · 63909J108
|
10.0% |
1/31/2025
Event 1/31/2025
|
|||
| Perceptive Advisors LLC | 10.0% | ||||
| Joseph Edelman | 10.0% | ||||
| Perceptive Life Sciences Master Fund, Ltd. | 9.9% | ||||
|
Traws Pharma, Inc.
13G
TRAW · 68232V884
|
9.9% |
1/8/2025
Event 12/31/2024
|
|||
| Perceptive Advisors LLC | 9.9% | ||||
| Joseph Edelman | 9.9% | ||||
| Perceptive Life Sciences Master Fund, Ltd | 9.9% | ||||